Skip to main content

Advertisement

SpringerLink
Log in

Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

Purpose: To describe the Gd-BOPTA MRI findings of intrahepatic mass-forming type cholangiocarcinomas (IMCs), with emphasis on the hepatobiliary phase (HBP). Methods: We reviewed retrospectively 29 IMC patients who underwent Gd-BOPTA-MRI between June, 2004 and June, 2014. Images were acquired prior to, and after, administration of 15–20 mL of Gd-BOPTA in the dynamic phase (arterial phase, portal venous phase, and 3–5 min phase), 10–15-min late phase, and 2–3 h HBP phase. Results: In the dynamic phase, 27 (93%) lesions showed a peripheral rim-like enhancement in the arterial and portal venous phases, followed by progressive filling-in on the delayed images. In 14 (56%) cases, a hypointense peripheral rim was identified in the 10–15-min late phase, delineating a target pattern. In the HBP, the cholangiocarcinoma showed a diffuse, mainly central and inhomogeneous enhancement (cloud of enhancement) in 28 (96%) patients; in 23 (79%) cases, there was an association between cloud appearance and a hypointense peripheral rim, showing a target pattern. Conclusions: Gd-BOPTA MRI pattern of IMC on dynamic study is similar to that of conventional extracellular agents, that is peripheral enhancement with progressive and concentric filling of contrast material on delayed phases. At 10–15 min delayed phases, IMC shows often a peripheral hypointense rim consistent with a target appearance. In the HBP, due to progressive central enhancement (cloud) and peripheral hypointense rim, an higher number of tumors show a target appearance; this pattern is not specific and would also be expected to be seen in metastases from adenocarcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

IMC:

Intrahepatic mass-forming cholangiocarcinoma

HBP:

Hepatobiliary phase

References

  1. Nakeeb A, Pitt HA, Sohn TA, et al. (1996) Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224:463–473

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Patel T (2011) Cholangiocarcinoma: controversies and challenges. Nat Rev Gastroenterol Hepatol 8:189–200

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Tanimoto A, Lee JM, Murakami T, et al. (2009) Consensus report of the 2nd International Forum for Liver MRI. Eur Radiol 19(Suppl 5):S975–S989

    Article  PubMed  Google Scholar 

  4. Jeon TY, Kim SH, Lee WJ, Lim HK (2010) The value of gadobenatedimeglumine–enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma. Abdom Imaging 35:337–345

    Article  PubMed  Google Scholar 

  5. Kim YK, Lee JM, Kim CS (2004) Gadobenatedimeglumine–enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions. Eur Radiol 14:5–13

    Article  PubMed  Google Scholar 

  6. Gabata T, Matusi O, Kadoya M, et al. (1998) Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance. Abdom Imaging 23:309–313

    Article  CAS  PubMed  Google Scholar 

  7. Grazioli L, Bondioni MP, Faccioli N, et al. (2010) Solid focal liver lesions: dynamic and late enhancement patterns with the dual phase contrast agent gadobenatedimeglumine. J Gastrointest Cancer 41(4):221–232

    Article  CAS  PubMed  Google Scholar 

  8. Hwang HS, Kim SH, Jeon TY, et al. (2009) Hypointense hepatic lesions depicted on gadobenatedimeglumine-enhanced three-hour delayed hepatobiliary-phase MR imaging: differentiation between benignancy and malignancy. Korean J Radiol 10:294–302

    Article  PubMed Central  PubMed  Google Scholar 

  9. Schneider G, Altmeyer K, Kirchin MA, et al. (2007) Evaluation of a novel time-efficient protocol for gadobenatedimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging. Invest Radiol 42:105–115

    Article  CAS  PubMed  Google Scholar 

  10. Hamrick-Turner J, Abbitt PL, Ros PR (1992) Intrahepatic cholangiocarcinoma: MR appearance. AJR 158:77–79

    Article  CAS  PubMed  Google Scholar 

  11. Vilgrain V, Van Beers BE, Flejou JF, et al. (1997) Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J Comput Assist Tomogr 21(1):59–65

    Article  CAS  PubMed  Google Scholar 

  12. Ros PR, Buck JL, Goodman ZD, ViamonteRos AM, Olmsted WW (1988) Intrahepatic cholangiocarcinoma: radiologic-pathologic correlation. Radiology 167:689–693

    Article  CAS  PubMed  Google Scholar 

  13. Maetani Y, Itoh K, Watanabe C, et al. (2001) MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR 176:1499–1507

    Article  CAS  PubMed  Google Scholar 

  14. Yoshida Y, Imai Y, Murakami T, et al. (1999) Intrahepaticcholangiocarcinoma with marked hypervascularity. Abdom Imaging 24:66–68

    Article  CAS  PubMed  Google Scholar 

  15. Yoshikawa J, Matsui O, Kadoya M, et al. (1992) Delayed enhancement of fibrotic areas in hepatic masses: CT-pathologic correlation. J Comput Assist Tomogr 16(2):206–211

    Article  CAS  PubMed  Google Scholar 

  16. Kim SH, Lee CH, Kim BH, et al. (2012) Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyldiethylenetriaminepentaacetic acid-enhanced magnetic resonance imaging. J Comput Assist Tomogr 36(6):704–709

    Article  PubMed  Google Scholar 

  17. Kajiyama K, Maeda T, Takenaka K, Sugimachi K, Tsuneyoshi M (1999) The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of “scirrhous-type” and “nonscirrhous-type” growth. Am J Surg Pathol 23:892–902

    Article  CAS  PubMed  Google Scholar 

  18. Lacomis JM, Baron RL, Oliver JH 3rd, Nalesnik MA, Federle MP (1997) Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology 203(1):98–104

    Article  CAS  PubMed  Google Scholar 

  19. Mahfouz AE, Hamm B, Wolf KJ (1994) Peripheral washout: a sign of malignancy on dynamic gadolinium enhanced MR images of focal liver lesions. Radiology 190:49–52

    Article  CAS  PubMed  Google Scholar 

  20. Jeong HT, Kim MJ, Chung YE, et al. (2013) Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. AJR Am J Roentgenol 201(4):W603–W611

    Article  PubMed  Google Scholar 

  21. Kang Y, Lee JM, Kim SH, Han JK, Choi BI (2012) Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology 264(3):751–760

    Article  PubMed  Google Scholar 

  22. Worawattanakul S, Semelka RC, Noone TC, et al. (1998) Cholangiocarcinoma: spectrum of appearances on MR images using current techniques. Magn Reson Imaging 16(9):993–1003

    Article  CAS  PubMed  Google Scholar 

  23. Schlund JF, Semelka RC, Kettritz U, et al. (1996) Correlation of perfusion abnormalities on CTAP and immediate postintravenous gadolinium-enhanced gradient echo MRI. Abdom Imaging 21:49–52

    Article  CAS  PubMed  Google Scholar 

  24. Soyer P, Bluemke DA, Vissuzaine C, et al. (1994) CT of hepatic tumors: prevalence and specificity of retraction of the adjacent liver capsule. AJR 162:1119–1122

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mediterranean Institute for Transplantation and Advanced Specialized Therapies (ISMETT) - University of Pittsburgh Medical Center (UPMC), Via Ernesto Tricomi 5, 90127, Palermo, Italy

    Giuseppe Mamone, Gianluca Marrone, Settimo Caruso, Vincenzo Carollo, Giovanni Gentile, Francesca Crino’, Mariapina Milazzo & Angelo Luca

Authors
  1. Giuseppe Mamone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gianluca Marrone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Settimo Caruso
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vincenzo Carollo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giovanni Gentile
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Francesca Crino’
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mariapina Milazzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Angelo Luca
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giuseppe Mamone.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mamone, G., Marrone, G., Caruso, S. et al. Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase. Abdom Imaging 40, 2313–2322 (2015). https://doi.org/10.1007/s00261-015-0445-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-015-0445-5

Keywords

Search

Navigation